Skip to main content
NIH funding notice PAR-16-166

Integrating Biospecimen Science into Clinical Assay Development (U01)

Closed on June 22, 2018.

Posted
April 5, 2016
Close date
June 22, 2018
Activity codes
U01
Institutes taking part
NCI

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page names no earlier notice: it is new, or it does not say.

Replaced by PAR-18-947.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $715,031 in first-year total cost, median $357,516.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 RPRB-N (J2)]1
  2. Special Emphasis Panel[ZCA1 SRB-2 (J1)]1

Most frequent institutions

  1. UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
  2. UNIVERSITY OF TX MD ANDERSON CAN CTR1
Competing awards under PAR-16-166 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Mitigation of preanalytic factors influencing brain tumor protein phosphorylation1U01CA229345-01A1PHILLIPS, JOANNAUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$366,857ZCA1
2017Integrating Biospecimen Science Into The Development Of RNA-Based Clinical Assays For Patients With Metastatic Breast Cancer1U01CA215547-01SYMMANS, WILLIAM FUNIVERSITY OF TX MD ANDERSON CAN CTR, TX$348,174ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.